Established and potential cardiovascular risk factors in metabolic syndrome: Effect of bariatric surgery
Affiliation
Faculty of Biology, Medicine and Health, University of ManchesterIssue Date
2023
Metadata
Show full item recordAbstract
Purpose of review: The aim of this review was to provide an overview of the role of novel biomarkers in metabolic syndrome, their association with cardiovascular risk and the impact of bariatric surgery on these biomarkers. Recent findings: Metabolic syndrome encompasses an intricate network of health problems, and its constituents extend beyond the components of its operational definition. Obesity-related dyslipidaemia not only leads to quantitative changes in lipoprotein concentration but also alteration in qualitative composition of various lipoprotein subfractions, including HDL particles, rendering them proatherogenic. This is compounded by the concurrent existence of obstructive sleep apnoea (OSA) and nonalcoholic fatty liver disease (NAFLD), which pave the common pathway to inflammation and oxidative stress culminating in heightened atherosclerotic cardiovascular disease (ASCVD) risk. Bariatric surgery is an exceptional modality to reverse both conventional and less recognised aspects of metabolic syndrome. It reduces the burden of atherosclerosis by ameliorating the impact of obesity and its related complications (OSA, NAFLD) on quantitative and qualitative composition of lipoproteins, ultimately improving endothelial function and cardiovascular morbidity and mortality. Summary: Several novel biomarkers, which are not traditionally considered as components of metabolic syndrome play a crucial role in determining ASCVD risk in metabolic syndrome. Due to their independent association with ASCVD, it is imperative that these are addressed. Bariatric surgery is a widely recognized intervention to improve the conventional risk factors associated with metabolic syndrome; however, it also serves as an effective treatment to optimize novel biomarkers.Citation
Bashir B, Adam S, Ho JH, Linn Z, Durrington PN, Soran H. Established and potential cardiovascular risk factors in metabolic syndrome: Effect of bariatric surgery. Current opinion in lipidology. 2023 Aug 15. PubMed PMID: 37560987. Epub 2023/08/10. eng.Journal
Current Opinion in LipidologyDOI
10.1097/mol.0000000000000889PubMed ID
37560987Additional Links
https://dx.doi.org/10.1097/mol.0000000000000889Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1097/mol.0000000000000889
Scopus Count
Collections
Related articles
- Correlation between Obstructive Sleep Apnea and Non-Alcoholic Fatty Liver Disease before and after Metabolic Bariatric Surgery.
- Authors: Zhang YX, Yang L, Yang CC, Wang WY, Shen JH, Shi ML, Yu Y, Dai QC, Gu Y, Yang JJ, Yu WW, Yao K, Hu M, Ni J, Sun JL, Zhang L, Sun HX, Lu XF, Wang B
- Issue date: 2020 Oct
- Non-alcoholic fatty liver disease is an independent risk factor for inflammation in obstructive sleep apnea syndrome in obese Asian Indians.
- Authors: Bhatt SP, Guleria R, Vikram NK, Gupta AK
- Issue date: 2019 Mar
- A Bidirectional Association Between Obstructive Sleep Apnea and Metabolic-Associated Fatty Liver Disease.
- Authors: Preshy A, Brown J
- Issue date: 2023 Sep
- The impact of obstructive sleep apnea on nonalcoholic fatty liver disease in patients with severe obesity.
- Authors: Benotti P, Wood GC, Argyropoulos G, Pack A, Keenan BT, Gao X, Gerhard G, Still C
- Issue date: 2016 Apr
- Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome.
- Authors: Drager LF, Togeiro SM, Polotsky VY, Lorenzi-Filho G
- Issue date: 2013 Aug 13